Europe Platelet-Rich Plasma Market ****** Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

Platelet-rich plasma, also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Europe platelet-rich plasma market includes market size for platelet-rich plasma systems and platelet-rich plasma kits.

The market report includes Europe platelet-rich plasma market value analysis by product type, applications, end user and country.

Europe platelet-rich plasma market holds huge growth potential and is expected to expand at 9.2% CAGR over 2019-2026. 

PRP Systems 

Platelet-rich plasma systems included in this report are centrifuge systems specifically for separation of platelet-rich plasma and platelet poor plasma from autologous blood samples drawn at the point-of-care facility.

Other centrifuge systems which have application in other cellular therapies and preparation of substances derived from body fluids are excluded from the scope of this report

Examples of PRP systems included in this report are GPS® III Platelet Concentration System (Zimmer Biomet), The Arthrex ACP® Double Syringe System (Arthrex Inc), Arthrex Angel® cPRP Processing System (Arthrex Inc.) etc. among others

PRP Kits 

PRP kits considered in this segment of the report include PRP preparation kits and PRP harvest kits. PRP Kit that makes Platelet-Rich Plasma extractions simple and cost-efficient

PRP preparation and harvest kits generally include PRP Tubes, Re-Suspension Tube, injectors, needles, phlebotomy sets etc.

PRP kits are made available to end users through three prominent sales channels. Sales channels included in this report are Direct Sales Channels, Distributor Sale Channels, and Others (group purchasing organisations, wholesalers, pharmacists etc.)

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=136&page=requestsample

Market Dynamics:  

  • Sales Channel 

Being low margin product, direct sales channel sub-segment of PRP kits product type is the most popular

  • End User  

All clinics segments collectively experience high demand for PRP kits in Europe

  • Applications

High demand for PRP kits is from cosmetic applications, including Skin rejuvenation, scar treatment, skin firming & whitening, fat grafting, hair loss treatment etc.

In U.K., PRP treatment industry is well established. However, there’s limited presence of domestic manufacturers of PRP kits in U.K. Hence, PRP kits are availed in the country through distributors that have partnership with manufacturing companies

Report Structure:  

Europe Platelet Rich Plasma Market, by Product Type 

  • Platelet-rich Plasma Systems
  • Kits & consumables (preparation kits, harvesting kits, etc.)

Europe Platelet Rich Plasma Market, by Application 

  • Cosmetic/Aesthetic/Hair Fall Treatment
  • Orthopedics/Rehabilitation medicine
  • Dentistry
  • Ophthalmology
  • Research and Development
  • Veterinary

Europe Platelet Rich Plasma Market, End Users 

  • Physician’s office/Private Practice/Veterinary Clinics
  • Hospitals
  • Orthopedic Clinics
  • Cosmetic/dermatology/Trichology Clinics
  • Academic & Research Institutes

Europe Platelet Rich Plasma Market, Region 

  • Germany
  • Italy
  • France
  • K.
  • Spain
  • Rest of the Europe

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=136&page=askfordiscount


Competitive Landscape:   

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

FutureWise Takeaways   

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key datapoints affecting market growth

Objectives of the Study:  

  • To provide with an exhaustive analysis on Europe platelet rich plasma market by product, application, end-user and region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and overall market
  • To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, and Latin America
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1.      Section 1
1.1.    About Us
1.2.    Overall Research Process
1.3.    Research Methodology
1.4.    Report Assumptions and Acronyms
1.5.    Forecasting Factors and Assumptions
2.      Section 2
2.1.    Market Purview
2.1.1. Report Description
2.1.2. Market Definition and Scope
2.2.    Executive Summary: Platelet-rich Plasma Market
2.2.1. Top 3 Market Findings
2.2.2. Top 3 Market Opportunity
2.2.3. Market Snippet By Region/Country
2.2.4. Market Snippet By Product Type
2.2.5. Market Snippet By Applications
2.3.    Coherent Opportunity Map (COM)
3.      Section 3
3.1.    Market Dynamics, Regulations, and Trends Analysis
3.1.1. Market Dynamics
3.1.1.1.              Drivers
3.1.1.1.1.                     Supply Side Drivers
3.1.1.1.2.                     Demand Side Drivers
3.1.1.1.3.                     Economic Drivers
3.1.1.2.              Restraints
3.1.1.3.              Market Opportunities
3.1.1.4.              Key Trends
3.2.    Porter’s Five Force Analysis: New Product Launch Perspective
3.3.    Products Application Analysis
3.4.    U.K. Platelet-Rich Plasma Market End User Analysis
4.      Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis,  2019 – 2026, By Product Type
4.1.    Key Findings
4.2.    Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Product Type (2019 ^ 2026)
4.3.    Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Product Type
4.3.1.  Platelet-Rich Plasma Systems
4.3.2. PRP Kits & Consumables
4.3.2.1.  Direct Sales
4.3.2.2.  Distributor Sales
4.3.2.3.  Group Purchasing Organizations
4.4.    Long Term ROI Segments, By Product Type
5.      Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis,  2019 – 2026, By Application
5.1.    Key Findings
5.2.    Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Application (2019 & 2026)
5.3.    Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Applications
5.3.1.  Dermatology/Plastic Surgery
5.3.2.  Orthopedics/Rehabilitation medicine
5.3.3.  Dentistry
5.3.4.  Ophthalmology
5.3.5.  Research and Development
5.3.6.  Veterinary
5.4.    Long Term ROI Segments, By Applications
6.      Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis,  2019 – 2026, By End User
6.1.    Key Findings
6.2.    Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By End Users
6.3.    Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By End Users
6.3.1.  Physician’s office/Private Practice
6.3.2.  Hospitals
6.3.3.  Orthopedic Clinics
6.3.4.  Cosmetic/dermatology/Trichology Clinics
6.3.5.  Academic & Research Institutes
6.4.    Long Term ROI Segments, By End Users
7.      Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis,  2019 – 2026, By Country
7.1.    Introduction & Key Findings
7.2.    Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Country
7.3.    Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Country
7.3.1.  Germany
7.3.2.  Italy
7.3.3.  France
7.3.4.  U.K.
7.3.5.  Spain
7.3.6.  Rest of the Europe
7.4.    Long Term ROI Segments, By Region
8.      Germany Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
8.1.    Key Findings
8.2.    Germany Platelet-rich Plasma Market Value Share Analysis
8.2.1.  By Product Type
8.2.2.  By Application
8.2.3.  By End User
8.2.4.  By Country
8.3.    Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.3.1.  Platelet-Rich Plasma Systems
8.3.2.  PRP Kits & Consumables
8.3.2.1.  Direct Sales
8.3.2.2.  Distributor Sales
8.3.2.3.  Group Purchasing Organizations
8.4.    Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.4.1.  Dermatology/Plastic Surgery
8.4.2.  Orthopedics/Rehabilitation medicine
8.4.3.  Dentistry
8.4.4.  Ophthalmology
8.4.5.  Research and Development
8.4.6. Veterinary
8.5.    End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.5.1.  Physician’s office/Private Practice
8.5.2.  Hospitals
8.5.3.  Orthopedic Clinics
8.5.4.  Cosmetic/dermatology/Trichology Clinics
8.5.5.  Academic & Research Institutes
8.6.    Germany Platelet-rich Plasma Market Trends
9.      Italy Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
9.1.    Key Findings
9.2.    Italy  Platelet-rich Plasma Market Value Share Analysis
9.2.1.  By Product Type
9.2.2.  By Application
9.2.3.  By End User
9.2.4.  By Country
9.3.    Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.3.1.  Platelet-Rich Plasma Systems
9.3.2.  PRP Kits & Consumables
9.3.2.1.  Direct Sales
9.3.2.2.  Distributor Sales
9.3.2.3.  Group Purchasing Organizations
9.4.    Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.4.1.  Dermatology/Plastic Surgery
9.4.2.  Orthopedics/Rehabilitation medicine
9.4.3.  Dentistry
9.4.4.  Ophthalmology
9.4.5.  Research and Development
9.4.6. Veterinary
9.5.    End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.5.1.  Physician’s office/Private Practice
9.5.2.  Hospitals
9.5.3.  Orthopedic Clinics
9.5.4.  Cosmetic/dermatology/Trichology Clinics
9.5.5.  Academic & Research Institutes
9.6.    Italy Platelet-rich Plasma Market Trends
10.  France   Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
10.1.Key Findings
10.2.France  Platelet-rich Plasma Market Value Share Analysis
10.2.1.      By Product Type
10.2.2.      By Application
10.2.3.      By End User
10.2.4.      By Country
10.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.3.1.      Platelet-Rich Plasma Systems
10.3.2.      PRP Kits & Consumables
10.3.2.1.             Direct Sales
10.3.2.2.             Distributor Sales
10.3.2.3.             Group Purchasing Organizations
10.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.4.1.      Dermatology/Plastic Surgery
10.4.2.      Orthopedics/Rehabilitation medicine
10.4.3.      Dentistry
10.4.4.      Ophthalmology
10.4.5.      Research and Development
10.4.6.    Veterinary
10.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.5.1.      Physician’s office/Private Practice
10.5.2.      Hospitals
10.5.3.      Orthopedic Clinics
10.5.4.      Cosmetic/dermatology/Trichology Clinics
10.5.5.      Academic & Research Institutes
10.6.France Platelet-rich Plasma Market Trends
11.  U.K. Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
11.1.Key Findings
11.2.U.K. Platelet-rich Plasma Market Value Share Analysis
11.2.1.      By Product Type
11.2.2.      By Application
11.2.3.      By End User
11.2.4.      By Country
11.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.3.1.      Platelet-Rich Plasma Systems
11.3.2.      PRP Kits & Consumables
11.3.2.1.             Direct Sales
11.3.2.2.             Distributor Sales
11.3.2.3.             Group Purchasing Organizations
11.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.4.1.      Dermatology/Plastic Surgery
11.4.2.      Orthopedics/Rehabilitation medicine
11.4.3.      Dentistry
11.4.4.      Ophthalmology
11.4.5.      Research and Development
11.4.6.    Veterinary
11.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.5.1.      Physician’s office/Private Practice
11.5.2.      Hospitals
11.5.3.      Orthopedic Clinics
11.5.4.      Cosmetic/dermatology/Trichology Clinics
11.5.5.      Academic & Research Institutes
11.6.U.K. Platelet-rich Plasma Market Trends
12.  Spain Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
12.1.Key Findings
12.2.Spain Platelet-rich Plasma Market Value Share Analysis
12.2.1.      By Product Type
12.2.2.      By Application
12.2.3.      By End User
12.2.4.      By Country
12.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.3.1.      Platelet-Rich Plasma Systems
12.3.2.      PRP Kits & Consumables
12.3.2.1.             Direct Sales
12.3.2.2.             Distributor Sales
12.3.2.3.             Group Purchasing Organizations
12.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.4.1.      Dermatology/Plastic Surgery
12.4.2.      Orthopedics/Rehabilitation medicine
12.4.3.      Dentistry
12.4.4.      Ophthalmology
12.4.5.      Research and Development
12.4.6.    Veterinary
12.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.5.1.      Physician’s office/Private Practice
12.5.2.      Hospitals
12.5.3.      Orthopedic Clinics
12.5.4.      Cosmetic/dermatology/Trichology Clinics
12.5.5.      Academic & Research Institutes
12.6.Spain Platelet-rich Plasma Market Trends
13.  Rest of the Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
13.1.Key Findings
13.2.Rest of the Europe Platelet-rich Plasma Market Value Share Analysis
13.2.1.      By Product Type
13.2.2.      By Application
13.2.3.      By End User
13.2.4.      By Country
13.2.5.      Rest of the Europe stitutes
13.3.Market Influencing Factors
14.  Europe Platelet-rich Plasma Market Competition
14.1.Competition Dashboard
14.2.Competitive Landscape
14.2.1.      Key Development Strategies
14.2.2.      Market Tier Structure Analysis
14.2.3.      Competitors Concentration, By Region
14.3.Platelet-rich Plasma Product Life Cycle Positioning
14.4.Company Profiles
14.4.1.      Terumo BCT
14.4.1.1.                      Overview
14.4.1.2.                      Product Portfolio
14.4.1.3.                      Financial Performance
14.4.1.4.                      Peer Comparison & 3C marketing equation
14.4.1.5.                      Company Strategy & Channel Management
14.4.2.      Zimmer Biomet
14.4.2.1.                      Overview
14.4.2.2.                      Product Portfolio
14.4.2.3.                      Financial Performance
14.4.2.4.                      Peer Comparison & 3C marketing equation
14.4.2.5.                      Company Strategy & Channel Management
14.4.3.      NeoGenesis Co. Ltd
14.4.3.1.                      Overview
14.4.3.2.                      Product Portfolio
14.4.3.3.                      Financial Performance
14.4.3.4.                      Peer Comparison & 3C marketing equation
14.4.3.5.                      Company Strategy & Channel Management
14.4.4.      Glofinn oy Overview
14.4.4.1.                      Product Portfolio
14.4.4.2.                      Financial Performance
14.4.4.3.                      Peer Comparison & 3C marketing equation
14.4.4.4.                      Company Strategy & Channel Management
14.4.5.      T Biotechnology (T Lab)
14.4.5.1.                      Overview
14.4.5.2.                      Product Portfolio
14.4.5.3.                      Financial Performance
14.4.5.4.                      Peer Comparison & 3C marketing equation
14.4.5.5.                      Company Strategy & Channel Management
14.4.6.      Regen Lab SA
14.4.6.1.                      Overview
14.4.6.2.                      Product Portfolio
14.4.6.3.                      Financial Performance
14.4.6.4.                      Peer Comparison & 3C marketing equation
14.4.6.5.                      Company Strategy & Channel Management
14.4.7.      SDD Medical Group Ltd Overview
14.4.7.1.                      Product Portfolio
14.4.7.2.                      Financial Performance
14.4.7.3.                      Peer Comparison & 3C marketing equation
14.4.7.4.                      Company Strategy & Channel Management
14.4.8.      IntraVita International Limited Overview
14.4.8.1.                      Product Portfolio
14.4.8.2.                      Financial Performance
14.4.8.3.                      Peer Comparison & 3C marketing equation
14.4.8.4.                      Company Strategy & Channel Management
14.4.9.      Exactech Inc.
14.4.9.1.                      Overview
14.4.9.2.                      Product Portfolio
14.4.9.3.                      Financial Performance
14.4.9.4.                      Peer Comparison & 3C marketing equation
14.4.9.5.                      Company Strategy & Channel Management
14.4.10.  Arthrex Inc.
14.4.10.1.                   Overview
14.4.10.2.                   Product Portfolio
14.4.10.3.                   Financial Performance
14.4.10.4.                   Peer Comparison & 3C marketing equation
14.4.10.5.                   Company Strategy & Channel Management
14.4.11.  Biotechnology Institute (bti)
14.4.11.1.         Overview
14.4.11.2.         Product Portfolio
14.4.11.3.         Financial Performance
14.4.11.4.         Peer Comparison & 3C marketing equation

 

Inquire further details about this report at: sales@futurewiseresearch.com

About FutureWise Research:

We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Contact Us:

Company Name: FutureWise Research
Contact Person:  Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City:  Leeds
Country:  United Kingdom
Website: www.futurewiseresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.